Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species

Vaccine

Volumn 30, Issue 1, 2011, Pages 5-8

  König, Patricia ^a   Blome, Sandra ^a   Gabriel, Claudia ^a   Reimann, Ilona ^a   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Candidate marker vaccine; Classical Swine Fever Virus (CSFV); CP7_E2alf; Innocuousness; Safety

Indexed keywords

BIOLOGICAL MARKER; VACCINE; DRUG CARRIER; MARKER VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CLASSICAL SWINE FEVER; CONTROLLED STUDY; FECES; GOAT; IMMUNITY; INOCULATION; LAMB; LEUKOCYTE; LEUKOPENIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEROLOGY; VACCINATION; VIRUS GENOME; ANIMAL; BLOOD; BOVINE DIARRHEA VIRUS; CATTLE; GENETICS; IMMUNOLOGY; NOSE CAVITY; ORAL DRUG ADMINISTRATION; PATHOGENICITY; SHEEP; SWINE; VIROLOGY; VIRUS SHEDDING;

ADMINISTRATION, ORAL; ANIMALS; BLOOD; CATTLE; CLASSICAL SWINE FEVER; DIARRHEA VIRUSES, BOVINE VIRAL; DRUG CARRIERS; FECES; GOATS; NASAL CAVITY; RABBITS; SHEEP; SWINE; VACCINES, MARKER; VIRAL VACCINES; VIRUS SHEDDING;

EID: 84858609598     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.064     Document Type: Article

References (18)

1. Edwards S, Fukusho A, Lefevre PC, Lipowski A, Pejsak Z, Roehe P, et al. Classical swine fever: the global situation. Vet Microbiol 2000;73:103-19.
2. Moennig V, Floegel-Niesmann G, Greiser-Wilke I. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J 2003;165:11-20.
3. Fauquet CM, Fargette D. International committee on taxonomy of viruses and the 3,142 unassigned species. Virol J 2005;2:64.
4. Anonymous. Council directive 2001/89/EC of 23 October 2001 on community measures for the control of classical swine fever. Off J Eur Commun 2001;L316:5-35.
5. Leifer I, Lange E, Reimann I, Blome S, Juanola S, Duran JP, et al. Modified live marker vaccine candidate CP7 E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Vaccine 2009;27:6522-9.
6. Beer M, Reimann I, Hoffmann B, Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007;25:5665-70.
7. van Oirschot JT. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003;96:367-84.
8. Reimann I, Depner K, Trapp S, Beer M. An avirulent chimeric pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 2004;322:143-57.
9. Koenig P, Lange E, Reimann I, Beer M. CP7 E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against classical swine fever virus (CSFV). Vaccine 2007;25:3391-9.
10. Tignon M, Kulcsar G, Haegeman A, Barna T, Fabian K, Levai R, et al. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs. Vet Microbiol 2010;142: 59-68.
11. Dong XN, Chen YH. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 2007;25:205-30.
12. Greiser-Wilke I, Dittmar KE, Liess B, Moennig V. Heterogeneous expression of the non-structural protein p80/p125 in cells infected with different pestiviruses. Gen Virol 1992;73:47-52.
13. Mittelholzer C, Moser C, Tratschin JD, Hofmann MA. Analysis of classical swine fever virus replication kinetics allows differentiation of highly virulent from avirulent strains. Vet Microbiol 2000;74:293-308.
14. Leifer I, Depner K, Blome S, Le Potier MF, Le Dimna M, Beer M, et al. Differentiation of C-strain Riems or CP7 E2alf vaccinated animals from animals infected by classical swine fever virus field strains using real-time RT-PCR. J Virol Methods 2009;158:114-22.
15. de Smit AJ, Bouma A, van Gennip HG, de Kluijver EP, Moormann RJ. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. Vaccine 2001;19:1467-76.
16. Rasmussen TB, Uttenthal A, Reimann I, Nielsen J, Depner K, Beer M. Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus. Gen Virol 2007;88:481-6.
17. Reimann I, Depner K, Utke K, Leifer I, Lange E, Beer M. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Vet Microbiol 2010;142:45-50.
18. Frölich K, Streich WJ. Serologic evidence of bovine viral diarrhea virus in freeranging rabbits from Germany. J Wildl Dis 1998;34:173-8.